Literature DB >> 10459899

Trials stopped early: too good to be true?

S Pocock1, I White.   

Abstract

Keywords:  Biomedical and Behavioral Research

Mesh：

Year:  1999        PMID： 10459899     DOI： 10.1016/S0140-6736(98)00379-1

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  18 in total

1.  Prophylaxis against early anaphylactic reactions to snake antivenom. Stopping trials early may result in insufficient evidence being accrued.

Authors:  D E Ball; K Tisocki
Journal:  BMJ       Date:  1999-10-02

Review 2.  Prospectively designed overviews of recent trials comparing antihypertensive regimens based on different drug classes.

Authors:  N Chapman; B Neal
Journal:  Curr Hypertens Rep       Date:  2001-08       Impact factor: 5.369

Review 3.  Screening for lung cancer using low-dose spiral CT: 10 years later, state of the art.

Authors:  M Zompatori; M Mascalchi; F Ciccarese; N Sverzellati; U Pastorino
Journal:  Radiol Med       Date:  2012-06-28       Impact factor: 3.469

4.  CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials.

Authors:  David Moher; Sally Hopewell; Kenneth F Schulz; Victor Montori; Peter C Gøtzsche; P J Devereaux; Diana Elbourne; Matthias Egger; Douglas G Altman
Journal:  BMJ       Date:  2010-03-23

5.  Necessary cautions when considering digoxin in heart failure.

Authors:  George A Heckman; Robert S McKelvie
Journal:  CMAJ       Date:  2007-02-27       Impact factor: 8.262

6.  What we have learned from the Myriad trials.

Authors:  S B Hendrix; G K Wilcock
Journal:  J Nutr Health Aging       Date:  2009-04       Impact factor: 4.075

7.  Association of Menopausal Hormone Therapy With Breast Cancer Incidence and Mortality During Long-term Follow-up of the Women's Health Initiative Randomized Clinical Trials.

Authors:  Rowan T Chlebowski; Garnet L Anderson; Aaron K Aragaki; JoAnn E Manson; Marcia L Stefanick; Kathy Pan; Wendy Barrington; Lewis H Kuller; Michael S Simon; Dorothy Lane; Karen C Johnson; Thomas E Rohan; Margery L S Gass; Jane A Cauley; Electra D Paskett; Maryam Sattari; Ross L Prentice
Journal:  JAMA       Date:  2020-07-28       Impact factor: 56.272

8.  Apparent declining efficacy in randomized trials: examples of the Thai RV144 HIV vaccine and South African CAPRISA 004 microbicide trials.

Authors:  Justin J O'Hagan; Miguel A Hernán; Rochelle P Walensky; Marc Lipsitch
Journal:  AIDS       Date:  2012-01-14       Impact factor: 4.177

9.  Adjuvant hepatic intra-arterial iodine-131-lipiodol following curative resection of hepatocellular carcinoma: a prospective randomized trial.

Authors:  A Y F Chung; L L P J Ooi; D Machin; S B Tan; B K P Goh; J S Wong; Y M Chen; P C N Li; M Gandhi; C H Thng; S W K Yu; B S Tan; R H G Lo; A M M Htoo; K H Tay; F X Sundram; A S W Goh; S P Chew; K H Liau; P K H Chow; K H Tay; Y M Tan; P C Cheow; C K Ho; K C Soo
Journal:  World J Surg       Date:  2013-06       Impact factor: 3.352

10.  Stopping randomized trials early for benefit: a protocol of the Study Of Trial Policy Of Interim Truncation-2 (STOPIT-2).

Authors:  Matthias Briel; Melanie Lane; Victor M Montori; Dirk Bassler; Paul Glasziou; German Malaga; Elie A Akl; Ignacio Ferreira-Gonzalez; Pablo Alonso-Coello; Gerard Urrutia; Regina Kunz; Carolina Ruiz Culebro; Suzana Alves da Silva; David N Flynn; Mohamed B Elamin; Brigitte Strahm; M Hassan Murad; Benjamin Djulbegovic; Neill K J Adhikari; Edward J Mills; Femida Gwadry-Sridhar; Haresh Kirpalani; Heloisa P Soares; Nisrin O Abu Elnour; John J You; Paul J Karanicolas; Heiner C Bucher; Julianna F Lampropulos; Alain J Nordmann; Karen E A Burns; Sohail M Mulla; Heike Raatz; Amit Sood; Jagdeep Kaur; Clare R Bankhead; Rebecca J Mullan; Kara A Nerenberg; Per Olav Vandvik; Fernando Coto-Yglesias; Holger Schünemann; Fabio Tuche; Pedro Paulo M Chrispim; Deborah J Cook; Kristina Lutz; Christine M Ribic; Noah Vale; Patricia J Erwin; Rafael Perera; Qi Zhou; Diane Heels-Ansdell; Tim Ramsay; Stephen D Walter; Gordon H Guyatt
Journal:  Trials       Date:  2009-07-06       Impact factor: 2.279
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.